Insilico Medicine has announced the launch of a dedicated Virtual Aging Cell webpage and introduced a preview of its multi-agent VAC platform, which incorporates biological age as a crucial modeling condition.
According to the company's press release, virtual cells are digital models that leverage artificial intelligence and mathematical modeling to simulate cell biology and its dynamic laws. Most existing approaches rely on single time-point data, depicting cells as static snapshots, which restricts their ability to model processes like differentiation, reprogramming, and aging.
The new Virtual Aging Cell (VAC) concept addresses this limitation by establishing biological age as a central conditional variable. The platform employs a multi-agent AI architecture to facilitate collaborative reasoning across six biological levels, ranging from molecular to organismal and populational. Its purpose is to dynamically simulate cell fate and provide computational support for target discovery, cell fate intervention, and geroprotective research.
Alex Zhavoronkov, founder and co-CEO of Insilico Medicine, highlighted that this development culminates a decade-long journey, evolving from a question posed at the 2014 NVIDIA GTC conference through a series of PreciousGPT models to the current platform. At the 2022 Gordon Research Conference, he proposed applying multimodal Transformers to aging research, which subsequently led to the creation of Precious1GPT, Precious2GPT, and Precious3GPT — models that integrate DNA methylation, transcriptomics, proteomics data, and textual representations to predict biological age and generate synthetic data.
The VAC platform augments these existing models with a multi-agent architecture, where “biological time” permeates all levels of reasoning. Agents can assess in real-time how changes in cell age impact tissue microenvironments, organs, and the organism as a whole, and can also model interventions ranging from target inhibition to environmental stimuli.
Petrina Kamya, Vice President at Insilico Medicine, emphasized that VAC unifies measurements previously considered in isolation, thereby creating a more dynamic environment for studying diseases and identifying new opportunities in drug development.
Further details are available on the Virtual Aging Cell webpage.
